-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Oaqgg8k2XBfVAtNKDxTVk4iSz3J9whEKeTTpPp03APQL4rjF6ZKYy2RdKj3kaZa5 4lvdOV/MoAdrEl/ySga77A== 0000950144-07-001752.txt : 20070301 0000950144-07-001752.hdr.sgml : 20070301 20070301080044 ACCESSION NUMBER: 0000950144-07-001752 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20070228 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20070301 DATE AS OF CHANGE: 20070301 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMSURG CORP CENTRAL INDEX KEY: 0000895930 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 621493316 STATE OF INCORPORATION: TN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-22217 FILM NUMBER: 07660505 BUSINESS ADDRESS: STREET 1: 20 BURTON HILLS BLVD STREET 2: STE 350 CITY: NASHVILLE STATE: TN ZIP: 37215 BUSINESS PHONE: 6156651283 MAIL ADDRESS: STREET 1: ONE BURTON HILLS BLVD. STREET 2: SUITE 350 CITY: NASHVILLE STATE: TN ZIP: 37215 8-K 1 g05778e8vk.htm AMSURG CORP. - FORM 8-K AMSURG CORP. - FORM 8-K
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 1, 2007 (February 28, 2007)
AMSURG CORP.
(Exact Name of Registrant as Specified in Charter)
         
Tennessee   000-22217   62-1493316
(State or Other Jurisdiction of   (Commission   (I.R.S. Employer
Incorporation)   File Number)   Identification No.)
     
20 Burton Hills Boulevard    
Nashville, Tennessee   37215
(Address of Principal Executive Offices)   (Zip Code)
(615) 665-1283
(Registrant’s Telephone Number, Including Area Code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
     o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 


 

Item 7.01. Regulation FD Disclosure
     On February 28, 2007, AmSurg Corp. issued a press release, the text of which is set forth as Exhibit 99.
Item 9.01. Financial Statements and Exhibits
     (c) 99 Press release dated February 28, 2007

2


 

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  AMSURG CORP.
 
 
  By:   /s/ Claire M. Gulmi    
    Claire M. Gulmi
 
 
    Executive Vice President and
Chief Financial Officer
(Principal Financial and Duly Authorized Officer) 
 
 
Date: March 1, 2007

3


 

INDEX TO EXHIBITS
         
Exhibit    
Number   Description
  99    
Press release dated February 28, 2007

4

EX-99 2 g05778exv99.htm EX-99 PRESS RELEASE 02/28/07 EX-99 PRESS RELEASE 02/28/07
 

Exhibit 99
Press Release
     
Contact:
  Claire M. Gulmi
 
  Executive Vice President and
 
  Chief Financial Officer
 
  (615) 665-1283
AMSURG CORP. TO PRESENT AT THE RAYMOND JAMES
28TH ANNUAL INSTITUTIONAL INVESTORS CONFERENCE
NASHVILLE, Tenn. (Feb. 28, 2007) — AmSurg Corp. (NASDAQ: AMSG) today announced that it will participate in the Raymond James 28th Annual Institutional Investors Conference on Wednesday, March 7, 2007 at the Hyatt Regency Grand Cypress in Orlando, Florida. In connection with the conference, there will be an on-line simulcast and a replay of the Company’s presentation available at the Company’s web site starting at 11:00 a.m. Eastern Time. Ken P. McDonald, President and Chief Executive Officer will be speaking at the conference.
     The live audio webcast and replay of the presentation will be available on the Company’s website by going to www.amsurg.com and clicking on Investors. For the live audio, please go to the site at least 15 minutes prior to the presentation to download and install any necessary audio software. The webcast replay will be available for 30 days.
     AmSurg Corp. develops, acquires and manages physician practice-based ambulatory surgery centers in partnership with surgical and other group practices. At December 31, 2006, AmSurg owned a majority interest in 156 continuing centers in operation and had five centers under development.
- END -

-----END PRIVACY-ENHANCED MESSAGE-----